(Q48869346)

16 February 2018

title

Adjuvant therapy with the pineal hormone melatonin in patients with lymph node relapse due to malignant melanoma. (English)

1 reference

16 February 2018

0 references

0 references

Lissoni P

1

1 reference

16 February 2018

Brivio O

2

1 reference

16 February 2018

Brivio F

3

1 reference

16 February 2018

Barni S

4

1 reference

16 February 2018

Tancini G

5

1 reference

16 February 2018

Crippa D

6

1 reference

16 February 2018

Meregalli S

7

1 reference

16 February 2018

publication date

1 November 1996

1 reference

16 February 2018

Journal of Pineal Research

published in

1 reference

16 February 2018

volume

21

1 reference

16 February 2018

issue

4

1 reference

16 February 2018

page(s)

239-242

1 reference

16 February 2018

Pineal melatonin inhibition of tumor promotion in theN-nitroso-N-methylurea model of mammary carcinogenesis: potential involvement of antiestrogenic mechanisms in vivo

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.1996.TB00292.X

A randomised study with subcutaneous low-dose interleukin 2 alone vs interleukin 2 plus the pineal neurohormone melatonin in advanced solid neoplasms other than renal cancer and melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.1996.TB00292.X

Serum interleukin 6 and C-reactive protein levels correlate with resistance to IL-2 therapy and poor survival in melanoma patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.1996.TB00292.X

Human malignant melanoma cells express high-affinity receptors for melatonin: antiproliferative effects of melatonin and 6-chloromelatonin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.1996.TB00292.X

10.1111/J.1600-079X.1996.TB00292.X

21 January 2018

Identifiers

DOI

1 reference

16 February 2018

PubMed ID

8989723

1 reference

16 February 2018